Decoy Therapeutics Inc.

US$1.13As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:DCOYHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (81.77%)
Div yield —
ROE (827.77%)
Biotechnology
Beta (5Y) 0.74
PE TTM —
TSR TTM (97.58%)
Mkt cap US$0.740M
ROIC (218.37%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.11
(1.57%)
(46.20%)
Hold 5|11|6|8|2
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
21.61%
6.65%
8.17%
13.56%
Revenue$M
0.057
0.056
0.056
0.059
2.47%
(2.40%)
(2.13%)
4.84%
Peers (US$0.740M)
Cap (US$)
PE
1.130M
—
0.915M
—
Capital
TTM
5Y
10Y
Leveragex
4.008
—
—
EBIT/Intx
1.077
0.062
0.065
Own earn%
(124.68)
(40.32)
(38.34)
Sh yield%
39.73
21.46
21.79
Owners
Insiders/Inst%
8.10
84.26
Short interest%
5.98
SBC / revenue%
4.73
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
19–23
$1 testx
—
Incr. ROIC%
5